Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: Differences in outcome are poorly explained by the most significant prognostic variables

British Journal of Haematology

Volumn 102, Issue 3, 1998, Pages 729-739

  Donadieu, Jean ^a   Auclerc, Marie Françoise ^b   Baruchel, André ^b   Leblanc, Thierry ^b   Landman Parker, Judith ^c   Perel, Yves ^d   Michel, Gérard ^e   Cornu, Gérard ^f   Bordigoni, Pierre ^g   Sommelet, Danielle ^g   Leverger, Guy ^c   Hill, Catherine ^a   Schaison, Gérard ^b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c ARMAND TROUSSEAU HOSPITAL   (France)

^d HÔPITAL PELLEGRIN   (France)

^e TIMONE HOSPITAL   (France)

^f Faculte de Medecine   (Belgium)

^g CHU NANCY BRABOIS   (France)

Author keywords

Acute lymphoblastic leukaemia; Childhood; Prognostic factors; Proportion of explained variation

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; AGE; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CYTOGENETICS; DISEASE COURSE; FEMALE; HUMAN; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; TREATMENT OUTCOME;

AGE FACTORS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; FRANCE; HUMANS; INFANT; INFANT, NEWBORN; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEX FACTORS; SURVIVAL ANALYSIS;

EID: 7344254683     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00818.x     Document Type: Article

References (58)

1. Arico, M., Basso, G., Mandelli, E. Rizzari, C., Colella, R., Barisone, E., Zanesco, L., Rondelli, R., Pession, A. & Masera, G. (1995) Good steroid response in vivo predicts a favorable outcome in children with T-cell acute lymphoblastic leukemia. Cancer, 75, 1684-1693.
2. Bahner-Ennassih, E., Suciu, S. & Bertrand, Y. (1995) Treatment results of the EORTC-Children's leukemia cooperative group (CLCG) protocols 588 31/2 in 177 children with T-cell lymphoblastic leukemia or non-Hodgkin lymphoma. Annals of Hematology, 70, 131.
3. Campana, D. & Pui, C.H. (1995) Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance. Blood, 85, 1416-1434.
4. Chessells, J.M., Bailey, C. & Richards, S.M. (1995) Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Lancet, 345, 145-147.
5. Collet, D. (1994) Modelling Survival Data in Medical Research. Chapman and Hall, London.
6. Cortes, J.E, & Kantarjian, H.M. (1995) Acute lymphoblastic leukemia: a comprehensive review with emphasis on biology and therapy. Cancer, 76, 2393-2417.
7. Crist, W., Boyett, J., Pullen, J., Van Eys, J. & Vietti, T. (1986) Clinical and biologic features predict poor prognosis in acute lymphoid leukemias in children and adolescents: Pediatric Oncology Group review. Medical Pediatric Oncology, 14, 135-139.
8. Crist, W., Carroll, A., Shuster, J., Behm, F.G., Whitehead, M., Vietti, T.J., Look, A.T. Mahoney, D., Ragab, A., Pullen, D.J. & Land, V.J. (1990a) Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1:19)(q23:p13): Pediatric Oncology Group study. Blood, 76, 117-122.
9. Crist, W., Carroll, A., Shuster, J., Jackson, J., Head, D., Borowitz, M., Behm, F., Link, M., Steuber, P., Ragab, A., Hirt, A., Brock, B., Land, V. & Pullen, J. (1990b) Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome: Pediatric Oncology Group study. Blood, 76, 489-494.
10. Eden, O.B., Lilleyman, J.S., Richards, S., Shaw, M.P. & Peto, J. (1991) Results of Medical Research Council childhood leukaemia trial UKALL VIII (report to the Medical Research Council on behalf of the working party on leukaemia in childhood). British Journal of Haematology, 78, 187-196.
11. Fletcher, J.A., Lynch, E.A., Kimball, V.A., Donnelly, M., Tantravahi, R. & Sallan, S.E. (1991) Translocation (9;22) is associated with extremely poor prognosis in intensively treated children with acute lymphoblastic leukemia. Blood, 77, 455-459.
12. Gajjar, A., Ribeiro, R., Hancock, M.L., Rivera, G.K., Mahmoud, H., Sandlund, J.T., Crist, W.M. & Pui, C.H. (1995) Persistence of circulating blasts after 1 week of multiagent chemotherapy confers a poor prognosis in childhood acute lymphoblastic leukemia. Blood, 86, 1292-1295.
13. Gibbons, B., Katz, F.E., Ganly, P. & Chessels, J.M. (1990) Infant acute lymphoblastic leukaemia with 1(11;19). British Journal of Haematology, 74, 264-269.
14. Hammond, D., Sather, H., Nesbit, M. Nesbit, M., Miller, D., Coccia, P., Bleyer, A., Lukens, J. & Siegel, S. (1986) Analysis of prognostic-factors in acute lymphoblastic leukemia. Medical Pediatric Oncology, 14, 124-154.
15. Harbott, J., Ritterbach, J., Janka-Schaub, G., Ludwig, W.D., Reiter, A., Riehm, H. & Lampert, F. (1990) Cytogenetics of childhood acute lymphoblastic leukemia in multicenter trials. Haematology and Blood Transfusion, 33, 451-458.
16. Hecker, S., Sauerbrey, A. & Volm, M. (1994) P53 expression and poor prognosis in childhood acute lymphoblastic leukemia. Anticancer Research, 14, 2559-2762.
17. Hiddeman, W., Sykora, R., Reiter, A., Ludwig, W.D., Schrappe, M., Harbott, J., Odenwald, E., & Riehm, H. (1995) Definition of a favorable prognostic subgroup in childhood ALL by high-grade DNA aneuploidy: a BFM study group report. Proceedings of the American Society for Clinical Oncology 12, 318.
18. Jacquillat, C., Weil, M., Auclerc, M.F., Chastang, C., Flandrin, G., Izrael, V., Schaison, G., Degos, L., Boiron, M. & Bernard, J. (1978) Prognosis and treatment ofx acute lymphoblastic leukemia. Cancer Chemotherapy and Pharmacology 1, 113-122.
19. Kaspers, G.J.L., Pieters, R., Van Zantwijk, C.H., Van Weering, E.R., Van der Does-Van den Berg, A. & Veerman, A.J.P. (1995) Drug resistance profile: strongest independent prognostic factor in childhood leukemia in a BFM-oriented treatment protocol. Annals of Hematology, 70, 129.
20. Lennard, L. & Lilleyman, J.S. (1989) Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia. Journal of Clinical Oncology, 7, 1816-1825.
21. Lilleyman, J.S., Hann, I.M., Stevens, S.M., Richards, S.M., Eden, O.B., Chessels, J.M. & Bailey, C.C. (1992) Cytomorphology of childhood leukaemia: a prospective study of 2000 patients. British Journal of Haematology 81, 52-57.
22. Look, A.T., Roberson, P.K., Williams, D.L., Rivera, G., Bowman, W.P., Pui, C.H., Ochs, J., Abromowitch, M., Kalwinsky, D., Dahl, G.V., George, S. & Murphy, S.B. (1985) Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemia. Blood, 65, 1079-1086.
23. McLean, T.W., Ringold, S., Neuberg, D., Stegmaier, K., Tantravahi, R., Ritz, J., Koeffler, H.P., Takeuchi, S., Janssen, J.W.G., Seriu, T., Bartam, C.R., Sallan, S.E., Gilliland, D.G. & Golub, T.R. (1996) TEL/AML 1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. Blood, 88, 4252-4258.
24. Mastrangelo, R., Poplack, D., Bleyer, A., Riccardi, R., Sather, H. & D'Angio, G. (1986) Report and recommendations of the Rome Workshop concerning poor-prognosis acute lymphoblastic leukemia in children: biologic bases for staging, stratification, and treatment. Medical Pediatric Oncology 14, 191-194.
25. Miller, D.R., Coccia, P.E., Bleyer, A., Lukens, J.N., Siegel, S.E., Sather, H.N. & Hammond, D. (1989) Early response to induction therapy as a predictor of disease-free survival and late recurrence of childhood acute lymphoblastic leukemia: a report from the childrens cancer study group. Journal of Clinical Oncology, 7, 1807-1815.
26. Miller, D.R., Leikin, S., Albo, V. Sather, H., Karon, M. & Hammond, D. (1983) Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG-141. Cancer, 51, 1041-1049.
27. Nagelkerke, N.J.D. (1991) A note on a general definition of coefficient of determination. Biometrika, 78, 691-692.
28. Neglia, J.P., Day, D.L., Swanson, T.V., Ramsay, N.K.C., Robison, L.L. & Nesbit, M.E. (1988) Kidney size at diagnosis of childhood leukemia: lack of prognostic significance for outcome. American Journal of Pediatric Hematology/Oncology, 10, 296-500.
29. Pieters, R., Kaspers, G.J.L., Klumper, E. & Veerman, A.J.P. (1994) Clinical relevance of in vitro resistance testing in childhood acute lymphoblastic leukemia: the state of the art. Medical Pediatric Oncology, 22, 299-308.
30. Pieters, R., Huismans, D.R., Loonene, A.H., Peters, G.J., Hählen, K., Van der Does-van den Berg, A., Van Wering, A.E. & Veerman, A.J.P. (1992) Adenosine deaminase and purine nucleoside phosphorylase in childhood lymphoblastic leukemia: relation with differentiation stage, in vitro drug resistance and clinical prognosis. Leukemia, 6, 375-380.
31. Pinkel, D. (1996) Selecting treatment for children with acute lymphoblastic leukemia. Journal of Clinical Oncology 14, 4-6.
32. Privitera, E., Kamps, M.P., Hayashi, Y., Inaba, T., Shapiro, L.H., Raimondi, S.C., Behm, R. Hendershot, L., Carroll, A.J., Baltimore, D. & Look, A.T. (1992) Different molecular consequences of the 1:19 chromosomal translocation in childhood B-cell precursor acute lymphoblastic leukemia. Blood, 79, 1781-1788.
33. Pui, C.H., Williams, D.L., Raimondi, S.C., Rivera, G.K., Look, A.T., Dodge, R.K., George, S.L., Behm, F.G., Crist, W.M. & Murphy, S.M. (1987) Hypodiploidy is associated with a poor prognosis in childhood acute lymphoblastic leukemia. Blood, 70, 247-253.
34. Pui, C.H., Frankel, L.S., Caroll, A.J., Raimondi, S.C., Shuster, J.J., Head, D.R., Crist, W.M., Land, V.J., Pullen, D.J., Steuber, C.P., Behm, F.G., & Borowitz, M.J. (1991) Clinical characteristics and treatment outcome of childhood lymphoblastic leukemia with t(4:11)(q21:q23): a collaborative study of 40 cases. Blood, 77, 440-447.
35. Pui, C.H., Raimondi, S.C., Dodge, R.K., Rivera, G.K., Fuchs, L.A.H., Abromowitch, M., Look, A.T., Furman, W.L., Crist, WM, & Williams, D.L. (1989) Prognostic importance of structural chomosomal abnormalities in children with hyperdiploid (>50 chromosomes) acute lymphoblastic leukemia. Blood, 73, 1963-1967.
36. Pui, C.H., Williams, D.L., Roberson, P.K., Behm, F.G., Lewis, S.H., Rivera, G.K., Kalwinsky, D.K., Abromowitch, M., Crist, W.M. & Murphy, S.M. (1988) Correlation of karyotype and immunophenotype in childhood acute lymphoblastic leukemia. Journal of Clinial Oncology, 6, 56-61.
37. Raimondi, S.C., Roberson, P.K., Pui, C.H., Behm, F.G. & Rivera, G.K. (1992) Hyperdiploid (47-50) acute lymphoblastic leukemia in children. Blood, 79, 3245-3252.
38. Rautonen, J., Hovi, L. & Siimes, M.A. (1988) Slow disappearance of peripheral blast cells: an independent risk factor indicating poor prognosis in children with acute lymphoblastic leukemia. Blood, 71, 989-991.
39. Reiter, A., Schrappe, M., Ludwig, W.D., Hiddemann, W., Sauter, S., Henze, G., Zimmermann, M., Lampert, F., Niethammer, D., Odenwald, E., Ritter, J., Mann, G., Welte, K., Gadner, H. & Riehm, H. (1994) Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients: results and conclusions of multicenter trial ALL-BFM 86, Blood, 84, 3122-3133.
40. Ribeiro, R.C. & Pui, C.H. (1995) Prognostic factors in childhood leukemia. Hematological Pathology, 7, 121-142.
41. Richards, S., Gray, S., Peto, R., Gaynon, P. & Masera, G. (1996) Duration and intensity of maintenance chemotherapy in acute lymphoblastic leukaemia: overview of 42 trials involving 12000 randomised children. Lancet, 347, 1783-1788.
42. Riehm, H., Reiter, A., Schrappe, M., Berthold, F., Dopfer, R., Gerein, V., Ludwig, R., Ritter, J., Stollman, B. & Henze, G. (1986) Die Corticosteroid-abhängige Dezimierung der Leukämiezellzahl im Blut als Prognosefaktor bei der Akuten Lymphoblastischen Leukämie im Kindesalter (Therapiestudie ALL-BFM 83). Klinische Pädiatric, 199, 151-160.
43. Rivera, G.K., Pinkel, D., Simone, J.V., Hancock, M.L. & Crist, W.M. (1995) Treatment of acute lymphoblastic leukemia. 30 year's experience at St Jude Children's Research Hospital. New England Journal of Medicine, 329, 1289-1295.
44. Robison, L., Sather, H., Coccia, P., Nesbit, M.E. & Hammond, G.D. (1980) Assessment of the interrelationship of prognostic factors in childhood acute lymphohlastic leukemia. American Journal of Pediatric Hematology and Oncology, 1, 3-5.
45. Russo, C., Carroll, A., Kohler, S., Borowitz, M., Amylon, M., Homans, M., Kedar, A., Shuster, J., Land, V., Crist, W., Pullen, J. & Link, M. (1991) Philadelphia chromosome and monosomy 7 in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood, 77, 1050-1056.
46. Santana, V.M., Dodge, R.K., Crist, W.M., Rivera, G.K., Look, A.T., Behm, F.G., Raimondi, S.C. & Pui, C.H. (1990) Presenting features and treatment outcome of adolescents with acute lymphoblastic leukemia. Leukemia, 4, 87-90.
47. Schaison, G., Sommelet, D., Bancillon, A., Perel, Y. Leblanc, T., Bergeron, C., Lejars, O., Baruchel, A., Lepage, E. & Leverger, G. (1992) Treatment of acute lymphoblastic leukemia: French protocol Fralle 85-87. Leukemia, 6, 148-152.
48. Schemper, M. & Smith, T.L. (1996) A note on quantifying follow-up in studies of failure time. Controlled Clinical Trials, 17, 545-346.
49. Schemper, M. & Stare, J. (1996) Explained variation in survival analysis. Statistics in Medicine, 15, 1999-2012.
50. Schorin, M.A., Blattner, S., Gelber, R.D., Tarbell, N.J., Donnelly, M., Dalton, V., Cohen, H.J. & Sallan, S.E. (1994) Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute/Children's Hospital acute lymphoblastic leukemia consortium Protocol 85-01. Journal of Clinial Oncology, 12, 740-747.
51. Secker-Walker, L.M., Chessels, J.M., Stewart, E.L., Swansbury, G.J., Richards, S. & Lawler, S.D. (1989) Chromosomes and other prognostic factors in acute lymphoblastic leukaemia: a long-term follow-up. British Journal of Haematology, 72, 336-342.
52. Smith, M., Arthur, D., Camitta, B., Caroll, A.J., Crist, W., Gaynon, P., Gelber, R., Heerema, N., Korn, E.L., Link, M., Murphy, S., Pui, C.H., Pullen, J., Reaman, G., Sallan, S.E., Sather, H., Shuster, J., Simon, R., Trigg, M., Tubergen, D., Uckun, F. & Ungerleider, R. (1996) Uniform approach to risk-classification and treatment assignment for children with ALL. Jonnml of Clinial Oncology, 14, 18-24.
53. Steinherz, P.G., Gaynon, P.S., Breneman, J.C., Cherlow, J.M., Grossman, N.J., Kersey, J.H., Johnstone, H.S., Sather, H.N., Trigg, M.E., Chappell, R., Hammond, D. & Bleyer, W.A. (1996) Cytoreduction and prognosis in acute lymphoblastic leukemia: the importance of early marrow response: report from the Childrens Cancer Study Group. Journal of Clinial Oncology, 14, 389-398.
54. Steinherz, RC., Siegel, S.E., Bleyer, W.A., Kersey, J., Chard, R., Coccia, P., Leikin, S., Lukens, J., Neerhout, R., Nesbit, M., Miller, D.R., Reaman, G. & Sather, H. (1991) Lymphomatous presentation of childhood acute lymphoblastic leukemia. Cancer, 68, 751-758.
55. Uckun, F.M., Sather, H., Gaynon, P., Arthur, D.C., Trigg, M.E., Tubergen, D.G., Nachman, J., Steinherz, P.G., Sensel, M.G. & Reaman, G.H. (1497) Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood, 90, 28-55.
56. Uckun, F.M., Sather, H., Reaman, G., Shuster, J., Land, V., Trigg, M., Gunther, R., Chelstrom, L., Bleyer, A., Gaynon, P. & Crist, W. (1995) Leukemic cell growth in SCID mice as a predictor of relapse in high-risk B-lineage acute lymphoblastic leukemia. Blood, 85, 873-878.
57. Uckun, F.M., Steinherz, P.G., Sather, H., Trigg, M., Arthur, D., Tubergen, D., Gaynon, P. & Reaman, G. (1996) CD2 antigen expression on leukemic cells as a predictor of event-free survival after chemotherapy for T-lineage acute lymphoblastic leukemia: a Children's Cancer Group study. Blood, 88, 4288-4295.
58. Wiersma, S.R., Ortega, J., Sobell, E. & Weinberg, K.I. (1991) Clinical importance of inyeloid-antigen expression in acute lymphoblastic leukemia in childhood. New England Journal of Medicine, 324, 800-808.